Crispr Therapeutics AG (CRSP) support and resistance · rev $11.6M
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
This page maps Crispr Therapeutics AG (CRSP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
CRSP currently screens at market cap $5.42B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRSP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRSP quote page for the session range and the stock page for the full model.
Not investment advice.